PEDIATRIC PULMONOLOGY
Scope & Guideline
Advancing pediatric respiratory health through innovative research.
Introduction
Aims and Scopes
- Pediatric Respiratory Diseases:
The journal covers a broad spectrum of respiratory diseases affecting children, including asthma, cystic fibrosis, bronchopulmonary dysplasia, and pneumonia, providing insights into their pathophysiology, diagnosis, and management. - Innovative Treatment Modalities:
Research on the efficacy of new therapies, such as CFTR modulators for cystic fibrosis, and biologics for asthma is a key focus, reflecting the journal's commitment to advancing treatment options for pediatric patients. - Longitudinal and Epidemiological Studies:
The journal publishes studies that examine the long-term outcomes and epidemiological trends of respiratory diseases in children, contributing to a better understanding of disease progression and public health implications. - Clinical Practice Guidelines:
Pediatric Pulmonology seeks to provide clinical practitioners with updated guidelines and consensus statements to improve the management of respiratory conditions in children, ensuring that care is evidence-based. - Interdisciplinary Approaches:
The journal emphasizes collaborative approaches in managing complex respiratory issues, encouraging contributions from various specialties including pulmonology, immunology, and nutrition.
Trending and Emerging
- Telehealth and Remote Monitoring:
The COVID-19 pandemic has accelerated the adoption of telehealth in pediatric pulmonology. Recent publications emphasize the efficacy and practicality of remote monitoring and consultations for managing chronic respiratory conditions. - Impact of Environmental Factors:
There is an increasing focus on how environmental exposures, such as air pollution and climate change, affect respiratory health in children, highlighting the need for research on preventive strategies. - Long-COVID and Post-Infectious Sequelae:
Emerging research on the long-term respiratory effects of COVID-19 in children reflects a growing concern about post-infectious syndromes and their management. - Psychosocial Factors in Respiratory Health:
Recent studies are increasingly exploring the interplay between mental health and respiratory conditions, recognizing the importance of addressing psychological well-being in pediatric patients. - Personalized Medicine Approaches:
The journal is increasingly featuring research on personalized medicine, particularly in the context of cystic fibrosis, where genotype-specific treatments are becoming more common.
Declining or Waning
- Traditional Diagnostic Techniques:
There has been a noticeable decline in publications focusing on conventional diagnostic methods for respiratory diseases, as newer, more advanced techniques such as lung ultrasound and biomarkers gain prominence. - General Pediatric Respiratory Infections:
Research on routine pediatric respiratory infections, such as common colds or mild bronchiolitis, appears to be decreasing, possibly due to a shift towards more severe or complex cases and their long-term impacts. - Single-Institution Studies:
The journal is moving away from publications centered on single-center studies, favoring multi-center and collaborative research efforts that provide broader insights and applicability. - Basic Science Research:
There is a waning interest in basic science research related to pediatric pulmonology, as the focus shifts towards translational and clinical research that directly impacts patient care. - Historical Perspectives:
Publications that provide historical overviews or retrospective analyses seem to have decreased, with a greater emphasis on current trends and future directions in pediatric respiratory care.
Similar Journals
Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine
Pioneering Open Access for Global Medical AdvancementClinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.
Therapeutic Advances in Respiratory Disease
Transforming Respiratory Medicine Through InnovationTherapeutic Advances in Respiratory Disease is a prestigious open-access journal published by SAGE Publications Ltd, based in the United Kingdom. Since its inception in 2007, it has established itself as a leading platform for the dissemination of cutting-edge research in the fields of pulmonary and respiratory medicine and pharmacology. With an impressive impact factor and ranking—showing it is in the Q1 quartile in both Pharmacology (medical) and Pulmonary and Respiratory Medicine as of 2023—the journal's commitment to high-quality research is evident. In 2023, it ranks #32 out of 155 in Pulmonary and Respiratory Medicine and #57 out of 272 in Medical Pharmacology, positioning it in the 79th percentile across these disciplines. Open access since 2018, the journal ensures that its valuable content is readily accessible to a global audience of researchers, healthcare professionals, and students, facilitating the rapid exchange of knowledge that is crucial in the ever-evolving landscape of respiratory health. The journal's objectives include advancing understanding of respiratory diseases through innovative research and promoting the development of therapeutic strategies that improve patient outcomes, making it an essential resource for those dedicated to respiratory medicine.
Turkish Thoracic Journal
Advancing pulmonary health through innovative research.Turkish Thoracic Journal, published by AVES, is a prominent open-access platform dedicated to advancing the field of pulmonary and respiratory medicine. Since its establishment, the journal has aimed to disseminate significant research findings, clinical studies, and reviews that contribute to an improved understanding of respiratory health challenges, with a particular focus on the Turkish context and regional issues. With an E-ISSN of 2149-2530 and transitioning to open access in 2022, the journal enhances visibility and accessibility, inviting a global audience of researchers, clinicians, and students to engage with the latest scientific work. The Turkish Thoracic Journal has been indexed in major databases, although it faced a coverage discontinuation in Scopus between 2016 and 2022. Currently positioned within the 23rd percentile among its peers in the field, it invites submissions that explore innovative approaches to thoracic health, enriching the discourse in a vital area of medicine.
PULMONARY PHARMACOLOGY & THERAPEUTICS
Unveiling breakthroughs in pulmonary therapeutics.Welcome to Pulmonary Pharmacology & Therapeutics, a leading journal dedicated to the dissemination of innovative research and insights in the fields of pulmonary medicine and pharmacology. Published by Academic Press Ltd - Elsevier Science Ltd, this journal has made significant contributions to the academic community since its inception in 1997, with an ongoing commitment to relevant advancements projected through to 2024. With reputable Q2 rankings across vital categories including Biochemistry (medical), Medicine (miscellaneous), Pharmacology (medical), and Pulmonary and Respiratory Medicine, Pulmonary Pharmacology & Therapeutics is ranked in the top tier of its field, reflecting its impact on the discipline as evidenced by its Scopus rankings. Researchers, healthcare professionals, and students alike can access a wealth of high-quality articles that address the complexity of pulmonary diseases and therapeutic strategies, supporting research and clinical practice alike. Join the vibrant community contributing to this essential field and explore the latest findings that can drive change in patient care and therapeutic effectiveness.
KLINISCHE PADIATRIE
Connecting Ideas to Impact in Pediatric HealthcareKLINISCHE PADIATRIE is a prominent academic journal published by GEORG THIEME VERLAG KG since its inception in 1972. Based in Germany, this journal serves as a valuable resource for professionals and researchers in the fields of Pediatrics, Perinatology, and Child Health. With an ISSN of 0300-8630 and E-ISSN 1439-3824, it features a rich array of peer-reviewed articles that focus on child health and development, encompassing clinical practices, therapeutic advances, and interdisciplinary approaches to pediatric care. While the journal operates on a subscription basis, its impact within the academic community is evidenced by its ranking of Q3 in Pediatrics, Perinatology, and Child Health as of 2023, and it maintains a solid standing within Q4 in Medicine (miscellaneous). The journal aims to bridge the gap between emerging research and clinical practice, providing a platform for innovative ideas that enhance pediatric care. Researchers, medical professionals, and students alike will find KLINISCHE PADIATRIE an essential addition to their academic repertoire, fostering advancements in pediatric healthcare and enriching knowledge in this vital field.
Lung India
Pioneering the future of respiratory research.Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.
Boletin de Pediatria
Empowering Pediatric Care Through Rigorous ResearchBoletin de Pediatria is a distinguished journal dedicated to the field of pediatric medicine, serving as a valuable resource for researchers, clinicians, and students alike. Published by EDICIONES ERGON SA, this journal is committed to advancing the knowledge and practice of pediatric healthcare. With its ISSN 0214-2597 and E-ISSN 2340-5384, it strives to disseminate high-quality, peer-reviewed research that addresses the latest advancements and best practices in pediatrics. Although specific impact factor data is not currently available, the journal's rigorous publication standards maintain its reputation within the scientific community. Notably, while Boletin de Pediatria is not an open-access journal, it provides digital access options that ensure the wide distribution of critical pediatric research. With a commitment to improving child health outcomes, this journal plays an essential role in fostering innovation and collaboration among pediatric healthcare professionals globally.
Tuberkuloz ve Toraks-Tuberculosis and Thorax
Exploring critical insights in thoracic medicine.Tuberkuloz ve Toraks (Tuberculosis and Thorax) is a distinguished journal published by the TURKISH ASSOCIATION OF TUBERCULOSIS AND THORAX located in Turkey. Serving as a pivotal platform for researchers and practitioners in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, this journal has been disseminating vital research since 2003 and is committed to advancing knowledge and clinical practices related to tuberculosis and thoracic diseases. Although currently not an Open Access publication, its relevance is underscored by its rankings within Scopus, including a Q3 category in Critical Care and Intensive Care Medicine and a Q4 in Pulmonary and Respiratory Medicine, reflecting its significant contributions to the academic community. With a mission to foster the exchange of innovative ideas and encourage rigorous scholarly discourse, Tuberkuloz ve Toraks plays an essential role in addressing pressing health challenges associated with respiratory ailments and remains an invaluable resource for researchers, health professionals, and students dedicated to improving outcomes in thoracic health.
Current Respiratory Medicine Reviews
Delivering Critical Reviews in Respiratory MedicineCurrent Respiratory Medicine Reviews, published by Bentham Science Publishers Ltd, serves as a vital platform in the field of pulmonary and respiratory medicine. With an ISSN of 1573-398X and an E-ISSN of 1875-6387, this journal provides comprehensive reviews and critical analyses that address the latest advancements and emerging trends in respiratory health from 2006 to 2024. While categorized as Q4 in the 2023 rankings, the journal presents unique insights that cater to a diverse readership, including researchers, healthcare professionals, and students. Located in the United Arab Emirates, the publication is committed to enhancing knowledge and sharing impactful findings in respiratory medicine, as evidenced by its Scopus rank within the 10th percentile for the field. Although it does not operate under an open access model, it remains an essential resource for those dedicated to improving patient outcomes through informed research and practice.
Current Pulmonology Reports
Exploring the latest innovations in pulmonology.Current Pulmonology Reports, published by SPRINGER, stands as a vital resource in the realm of respiratory health, delivering peer-reviewed research that informs clinical practices and advances understanding within the field of pulmonology. With an E-ISSN of 2199-2428, this journal captures the latest findings and technological innovations pertinent to respiratory diseases, treatment protocols, and patient management strategies. Although currently classified as non-open access, it ensures robust dissemination of significant research contributions which are essential for professionals and scholars alike. The journal's objective is not only to foster a deeper understanding of lung health issues but also to bridge the gap between research and application, thereby impacting real-world practices. As the demand for comprehensive studies in pulmonology continues to grow, Current Pulmonology Reports seeks to maintain its position as a premier outlet for quality research, ultimately bettering outcomes in respiratory medicine.